Absorption, Metabolism, Excretion, and the Determination of Absolute Bioavailability of Niraparib in Subjects With Cancer

NCT02476552 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: Niraparib Oral Capsules (Labeled)
DRUG: Niraparib IV (Labeled)
DRUG: Niraparib Oral Capsules (Unlabeled)

Sponsor

Tesaro, Inc.